Amedisys, Inc.
BMV:AMED * 주식 보고서
Amedisys 대차 대조표 상태 Amedisys 의 총 주주 지분은 $1.2B 이고 총 부채는 $358.6M, 이는 부채 대 자기자본 비율을 30.4% 로 가져옵니다. 총자산과 총부채는 각각 $2.1B 및 $938.5M 입니다. Amedisys 의 EBIT는 $209.1M 이며 이자보상배율은 7.8 입니다. $149.9M 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보 이자 보상 비율 7.8x 현금 US$149.88m 주식 US$1.18b 총 부채 US$938.48m 총 자산 US$2.12b
최근 재무 상태 업데이트
모든 업데이트 표시
Michael P. North Leaves Amedisys, Inc. as Chief Information Officer and Compensation Committee of the Board of Directors, Effective August 31, 2024 Aug 23
Insufficient new directors Aug 08 Option Care Health, Inc. (NasdaqGS:OPCH) cancelled the acquisition of Amedisys, Inc. (NasdaqGS:AMED). Jun 27
Option Care Health, Inc. (NasdaqGS:OPCH) entered into an agreement and plan of merger to acquire Amedisys, Inc. (NasdaqGS:AMED) for $3.2 billion. May 05
Insufficient new directors Mar 14
Amedisys, Inc. (NasdaqGS:AMED) announces an Equity Buyback for $100 million worth of its shares. Feb 10
Amedisys, Inc. to Report Q4, 2022 Results on Feb 15, 2023 Jan 31
Insufficient new directors Jan 31
Insufficient new directors Jan 05
Amedisys, Inc. Names Scott Ginn as Acting Chief Operating Officer Nov 23 Amedisys, Inc. Announces CEO Changes
Amedisys, Inc. Provides Earnings Guidance for the Year 2022 Oct 29
Amedisys, Inc. to Report Q3, 2022 Results on Oct 26, 2022 Oct 19
Investor sentiment deteriorated over the past week Sep 29
High number of new directors Sep 29
Amedisys, Inc. Announces Resignation of David L. Kemmerly as Chief Legal and Government Affairs Officer Sep 24
Second quarter 2022 earnings released: EPS: US$0.91 (vs US$2.46 in 2Q 2021) Jul 28
High number of new directors Jul 18
Amedisys, Inc. to Report Q2, 2022 Results on Jul 27, 2022 Jul 07 Amedisys, Inc.(NasdaqGS:AMED) dropped from Russell 1000 Growth-Defensive Index
High number of new directors May 30
Investor sentiment deteriorated over the past week May 05
High number of new directors May 04
Amedisys, Inc. Announces Promotion of Nick Muscato as Chief Strategy Officer Apr 27
Amedisys, Inc. to Report Q1, 2022 Results on Apr 27, 2022 Apr 14 Amedisys, Inc. (NasdaqGS:AMED) completed the acquisition of Assets of AssistedCare Home Health, Inc. and RH Homecare Services, LLC.
High number of new directors Mar 29
Amedisys, Inc. Announces Resignation of Richard A. Lechleiter from the Board of Directors Mar 07
Investor sentiment improved over the past week Mar 03
High number of new directors Mar 01
Amedisys, Inc. (NasdaqGS:AMED) signed a definitive agreement to acquire Assets of AssistedCare Home Health, Inc. Feb 24
Amedisys, Inc. (NasdaqGS : AMED) agreed to acquire Evolution Health, LLC from Emergency Medical Services LP Corporation. Feb 03
Amedisys, Inc. to Report Q4, 2021 Results on Feb 23, 2022 Feb 01
High number of new directors Jan 19
Investor sentiment deteriorated over the past week Dec 08
Lead Independent Director recently bought Mex$3.0m worth of stock Dec 06
Third quarter 2021 earnings released: EPS US$1.38 (vs US$2.20 in 3Q 2020) Nov 04
Investor sentiment improved over the past week Nov 03
High number of new directors Oct 28
High number of new directors Oct 09
Independent Director recently sold Mex$42m worth of stock Sep 05
Second quarter 2021 earnings released: EPS US$2.46 (vs US$1.07 in 2Q 2020) Aug 08
Investor sentiment deteriorated over the past week Aug 06
High number of new directors Aug 06
President & COO recently sold Mex$1.5m worth of stock Jul 09
Amedisys, Inc. (NasdaqGS:AMED) entered into an Agreement to acquire Contessa Health, Inc. for $250 million. Jul 01
Amedisys, Inc. (NasdaqGS:AMED) entered into a definitive agreement to acquire Home Health and Hospice Operations of Visiting Nurse Association. May 12
Insider recently sold Mex$10m worth of stock May 02
Amedisys, Inc. Provides Revenue Guidance for the Full Year 2021 Apr 30
First quarter 2021 earnings released: EPS US$1.52 (vs US$0.98 in 1Q 2020) Apr 29
Amedisys, Inc. and Sound Physicians to Launch Home Health Advanced Pilot Program Apr 29
Independent Director recently bought Mex$5.3m worth of stock Mar 06
Revenue misses expectations Feb 26
Full year 2020 earnings released: EPS US$5.64 (vs US$3.95 in FY 2019) Feb 26
Amedisys, Inc. Announces Executive Changes Feb 26
Amedisys, Inc. Announces Executive Changes Feb 25
Amedisys, Inc. to Report Q4, 2020 Results on Feb 24, 2021 Feb 10
Amedisys, Inc.(NasdaqGS:AMED) dropped from Russell 2000 Dynamic Index Jan 28
Amedisys, Inc. and Option Care Health Inc. Collaborate to Provide Innovative COVID Therapy Access Model Jan 06
Ivanetta Davis Samuels Joins Amedisys, Inc.'s Board of Director Dec 16
Amedisys, Inc. to Report Q3, 2020 Results on Oct 28, 2020 Oct 14
Amedisys, Inc. to Report Q2, 2020 Results on Jul 28, 2020 Jul 18
Amedisys, Inc.(NasdaqGS:AMED) dropped from Russell 2000 Growth-Defensive Index Jul 04 Amedisys, Inc.(NasdaqGS:AMED) dropped from Russell 2000 Defensive Index
재무 상태 분석
단기부채: AMED * 의 단기 자산 ( $555.9M )이 단기 부채 ( $480.0M ).
장기 부채: AMED * 의 단기 자산( $555.9M )이 장기 부채 ( $458.5M ).
부채 대 자본 내역 및 분석
부채 수준: AMED * 의 순부채 대 자기자본 비율 ( 17.7% )은 satisfactory 로 간주됩니다.
부채 감소: AMED * 의 부채 대 자기자본 비율은 지난 5년간 48.1% 에서 30.4% 로 감소했습니다.
부채 범위: AMED * 의 부채는 영업 현금 흐름 ( 26.8% )에 의해 잘 충당 되었습니다.
이자 보장: AMED * 의 부채에 대한 이자 지급 은 EBIT ( 7.8 x 적용 범위)로 잘 충당 됩니다.
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}